RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis
Clinical trial NCT03016260 · TERMINATED
Trial details
- NCT number
- NCT03016260
- Sponsor
- TcLand Expression S.A.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-01
- Primary completion
- 2019-12-20
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.